DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

Sunesis Pharmaceuticals Q4 EPS $(0.05) Beats $(0.07) Estimate

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 68.75 percent increase over losses of $(0.16) per

Benzinga · 03/10/2020 20:10

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 68.75 percent increase over losses of $(0.16) per share from the same period last year.